Search

everythinglearnresearchcommunity

for

Search:↓

Combining PRP with CGF is more effective for hair regrowth in androgenetic alopecia than PRP alone.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Acne severity is not related to the type or severity of androgenetic alopecia.

Both low-level light therapy and 5% minoxidil are effective and safe for treating male hair loss, with no significant difference in results.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

The 1565 nm non-ablative fractional laser is more effective and satisfying than 5% minoxidil for treating hair loss.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

Androgenetic alopecia causes hair thinning in women, affecting their quality of life.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

The combination of tretinoin gel and minoxidil effectively improves hair growth and satisfaction in people with androgenetic alopecia.

PRP therapy for hair loss is safe but its effectiveness is doubtful.

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Women with androgenetic alopecia have lower zinc and iron levels.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Androgenetic alopecia is significantly linked to metabolic syndrome.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

High-frequency ultrasound can effectively visualize and assess hair loss.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.

Adenosine may help with hair loss, but more research is needed.

Dutasteride mesotherapy can cause hair loss in some people.

Injecting stem cells from a patient's own fat can improve hair growth in women with hair loss.

Topical sildenafil 1.0% may help increase hair count in female pattern hair loss.

Drinking sweetened tea and soda and poor sleep may increase the risk of hair loss in women.